Medicure Inc. (CVE:MPH – Get Free Report)’s stock price passed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of C$1.12 and traded as high as C$1.29. Medicure shares last traded at C$1.29, with a volume of 8,233 shares.
Medicure Price Performance
The company has a debt-to-equity ratio of 4.65, a quick ratio of 1.29 and a current ratio of 2.03. The company has a 50-day moving average price of C$1.13 and a 200-day moving average price of C$1.11. The firm has a market capitalization of C$14.92 million, a P/E ratio of -11.00 and a beta of 1.09.
About Medicure
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Featured Stories
- Five stocks we like better than Medicure
- Consumer Staples Stocks, Explained
- onsemi Places a $6 Billion Bet on Its Own Stock
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- HIMS Has Been a Roller Coaster Ride. Should Investors Hop On?
- Utilities Stocks Explained – How and Why to Invest in Utilities
- End the Year Strong With These 3 Comeback Champions
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
